Meridian Bioscience Provides FY 2013 Guidance
August 28, 2012
Meridian Bioscience Provides FY 2013 Guidance
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Dx Focus: Meridian's Illumigene Group A, B Strep Tests; Cynvenio Biosystems' LiquidBiopsy Service
March 21, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - Meridian Bioscience NAAT for Group A Strep Shines in Multicenter Clinical Study
March 7, 2013 / PCR Insider - Meridian Bioscience Reports 13 Percent Spike in Q1 Revenues Driven by Growth in Illumigene Products
January 24, 2013 / PCR Insider - US Diagnostics Business Drives up Meridian Bioscience Q1 Revenues 13 Percent
January 23, 2013 / GenomeWeb Daily News